Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Syncona Creates Second Gene Therapy Company With £25m Financing

This article was originally published in Scrip

Executive Summary

The Wellcome Trust's investment subsidiary Syncona LLP has put £25m of series A financing into a new gene therapy company, Freeline Therapeutics, spun off from University College London (UCL) via its technology transfer arm UCL Business PLC. Freeline's initial focus will be on bleeding disorders.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register